Near Infrared Fluorescence (NIRF) Molecular Imaging of Oxidized LDL with an Autoantibody in Experimental Atherosclerosis

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Khamis, Ramzi Y ^a   Woollard, Kevin J ^b   Hyde, Gareth D ^a   Boyle, Joseph J ^a   Bicknell, Colin ^b   Chang, Shang Hung ^a   Malik, Talat H ^b   Hara, Tetsuya ^c   Mauskapf, Adam ^c   Granger, David W ^d   Johnson, Jason L ^e   Ntziachristos, Vasilis ^c   Matthews, Paul M ^b   Jaffer, Farouc A ^c   Haskard, Dorian O ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d GLAXOSMITHKLINE   (United Kingdom)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTIGEN; AUTOANTIBODY; FLUORESCENT DYE; L01-750; LO 701; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MALONALDEHYDE; MATRIX METALLOPROTEINASE; OXIDIZED LOW DENSITY LIPOPROTEIN; PLANT EXTRACT;

ANIMAL; ATHEROSCLEROSIS; BLOOD; C57BL MOUSE; CHEMISTRY; CONFOCAL MICROSCOPY; CYTOLOGY; DEFICIENCY; DIAGNOSTIC IMAGING; FEMALE; FLUORESCENCE MICROSCOPY; GENETICS; HALF LIFE TIME; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; KNOCKOUT MOUSE; LIPID DIET; MACROPHAGE; METABOLISM; MICRO-COMPUTED TOMOGRAPHY; MOUSE; PATHOLOGY; RABBIT; THORACIC AORTA;

ALBENDAZOLE; ANIMALS; ANTIGENS; AORTA, THORACIC; ATHEROSCLEROSIS; AUTOANTIBODIES; DIET, HIGH-FAT; FEMALE; FLUORESCENT DYES; HALF-LIFE; HUMANS; IMMUNOHISTOCHEMISTRY; LIPOPROTEINS, LDL; MACROPHAGES; MALONDIALDEHYDE; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; PLANT EXTRACTS; RABBITS; RECEPTORS, LDL; X-RAY MICROTOMOGRAPHY;

EID: 84959449633     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep21785     Document Type: Article

References (34)

1. Libby, P., Ridker, P. M. & Hansson, G. K. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 54, 2129-2138, doi: 10.1016/j.jacc.2009.09.009 (2009).
2. Yla-Herttuala, S. et al. Stabilisation of atherosclerotic plaques. Position paper of the European Society of Cardiology (ESC) Working Group on atherosclerosis and vascular biology. Thromb Haemost 106, 1-19, doi: 10.1160/th10-12-0784 (2011).
3. Tian, J. et al. Distinct morphological features of ruptured culprit plaque for acute coronary events compared to those with silent rupture and thin-cap fibroatheroma: a combined optical coherence tomography and intravascular ultrasound study. J Am Coll Cardiol 63, 2209-2216, doi: 10.1016/j.jacc.2014.01.061 (2014).
4. Wykrzykowska, J. J. et al. Longitudinal distribution of plaque burden and necrotic core-rich plaques in nonculprit lesions of patients presenting with acute coronary syndromes. JACC Cardiovasc Imaging 5, S10-18, doi: 10.1016/j.jcmg.2012.01.006 (2012).
5. Stone, P. H. et al. Prediction of progression of coronary artery disease and clinical outcomes using vascular profiling of endothelial shear stress and arterial plaque characteristics: the PREDICTION Study. Circulation 126, 172-181, doi: 10.1161/ circulationaha.112.096438 (2012).
6. Jaffer, F. A. & Verjans, J. W. Molecular imaging of atherosclerosis: clinical state-of-the-art. Heart, doi: 10.1136/heartjnl-2011-301370 (2013).
7. Vasquez, K. O., Casavant, C. & Peterson, J. D. Quantitative whole body biodistribution of fluorescent-labeled agents by non-invasive tomographic imaging. PLoS One 6, e20594, doi: 10.1371/journal.pone.0020594 (2011).
8. Nahrendorf, M. et al. Hybrid in vivo FMT-CT imaging of protease activity in atherosclerosis with customized nanosensors. Arterioscler Thromb Vasc Biol 29, 1444-1451, doi: 10.1161/atvbaha.109.193086 (2009).
9. Hall, M. A. et al. Comparison of mAbs targeting epithelial cell adhesion molecule for the detection of prostate cancer lymph node metastases with multimodal contrast agents: quantitative small-animal PET/CT and NIRF. J Nucl Med 53, 1427-1437, doi: 10.2967/ jnumed.112.106302 (2012).
10. Nishi, K. et al. Oxidized LDL in carotid plaques and plasma associates with plaque instability. Arterioscler Thromb Vasc Biol 22, 1649-1654 (2002).
11. Sigala, F. et al. Oxidized LDL in human carotid plaques is related to symptomatic carotid disease and lesion instability. J Vasc Surg 52, 704-713, doi: 10.1016/j.jvs.2010.03.047 (2010).
12. van Dijk, R. A. et al. Differential expression of oxidation-specific epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesions. J Lipid Res 53, 2773-2790, doi: 10.1194/jlr.P030890 (2012).
13. Fefer, P. et al. The role of oxidized phospholipids, lipoprotein (a) and biomarkers of oxidized lipoproteins in chronically occluded coronary arteries in sudden cardiac death and following successful percutaneous revascularization. Cardiovasc Revasc Med 13, 11-19, doi: 10.1016/j.carrev.2011.08.001 (2012).
14. Tsimikas, S., Shortal, B. P., Witztum, J. L. & Palinski, W. In vivo uptake of radiolabeled MDA2, an oxidation-specific monoclonal antibody, provides an accurate measure of atherosclerotic lesions rich in oxidized LDL and is highly sensitive to their regression. Arterioscler Thromb Vasc Biol 20, 689-697 (2000).
15. Shaw, P. X. et al. Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo. Arterioscler Thromb Vasc Biol 21, 1333-1339 (2001).
16. Torzewski, M. et al. Reduced in vivo aortic uptake of radiolabeled oxidation-specific antibodies reflects changes in plaque composition consistent with plaque stabilization. Arterioscler Thromb Vasc Biol 24, 2307-2312, doi: 10.1161/01. ATV.0000149378.98458.fe (2004).
17. Briley-Saebo, K. C. et al. Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes. Circulation 117, 3206-3215, doi: 10.1161/circulationaha.107.757120 (2008).
18. Briley-Saebo, K. C., Cho, Y. S. & Tsimikas, S. Imaging of Oxidation-Specific Epitopes in Atherosclerosis and Macrophage-Rich Vulnerable Plaques. Curr Cardiovasc Imaging Rep 4, 4-16, doi: 10.1007/s12410-010-9060-6 (2011).
19. Briley-Saebo, K. C. et al. In vivo detection of oxidation-specific epitopes in atherosclerotic lesions using biocompatible manganese molecular magnetic imaging probes. J Am Coll Cardiol 59, 616-626, doi: 10.1016/j.jacc.2011.10.881 (2012).
20. Lu, T. et al. Near-infrared fluorescence imaging of murine atherosclerosis using an oxidized low density lipoprotein-targeted fluorochrome. Int J Cardiovasc Imaging 30, 221-231, doi: 10.1007/s10554-013-0320-9 (2014).
21. Chang, S. H. et al. Model IgG monoclonal autoantibody-anti-idiotype pair for dissecting the humoral immune response to oxidized low density lipoprotein. Hybridoma 31, 87-98 (2012).
22. Lin, S. A. et al. Quantitative Longitudinal Imaging of Vascular Inflammation and Treatment by Ezetimibe in apoE Mice by FMT Using New Optical Imaging Biomarkers of Cathepsin Activity and alpha(v)beta(3) Integrin. Int J Mol Imaging 2012, 189254, doi: 10.1155/2012/189254 (2012).
23. Waschkau, B., Faust, A., Schafers, M. & Bremer, C. Performance of a new fluorescence-labeled MMP inhibitor to image tumor MMP activity in vivo in comparison to an MMP-activatable probe. Contrast Media Mol Imaging 8, 1-11, doi: 10.1002/cmmi.1486 (2013).
24. Wallis de Vries, B. M. et al. Images in cardiovascular medicine. Multispectral near-infrared fluorescence molecular imaging of matrix metalloproteinases in a human carotid plaque using a matrix-degrading metalloproteinase-sensitive activatable fluorescent probe. Circulation 119, e534-536, doi: 10.1161/circulationaha.108.821389 (2009).
25. Jaffer, F. A. et al. Two-dimensional intravascular near-infrared fluorescence molecular imaging of inflammation in atherosclerosis and stent-induced vascular injury. J Am Coll Cardiol 57, 2516-2526, doi: 10.1016/j.jacc.2011.02.036 (2011).
26. Calfon, M. A. et al. In vivo Near Infrared Fluorescence (NIRF) Intravascular Molecular Imaging of Inflammatory Plaque, a Multimodal Approach to Imaging of Atherosclerosis. J Vis Exp, doi: 10.3791/2257 (2011).
27. Olafsen, T. & Wu, A. M. Antibody vectors for imaging. Semin Nucl Med 40, 167-181, doi: 10.1053/j.semnuclmed.2009.12.005 (2010).
28. Stone, P. H., Coskun, A. U. & Prati, F. Ongoing Methodological Approaches to Improve the in Vivo Assessment of Local Coronary Blood Flow and Endothelial Shear Stress: The Devil is in the Details. J Am Coll Cardiol 66, 136-138, doi: 10.1016/j.jacc.2015.05.010 (2015).
29. Verhoeven, B. A. et al. Athero-express: differential atherosclerotic plaque expression of mRNA and protein in relation to cardiovascular events and patient characteristics. Rationale and design. Eur J Epidemiol 19, 1127-1133 (2004).
30. Bhatia, V. K. et al. Complement C1q reduces early atherosclerosis in low-density lipoprotein receptor-deficient mice. Am J Pathol 170, 416-426, doi: 10.2353/ajpath.2007.060406 (2007).
31. Yoo, H. et al. Intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo. Nat Med 17, 1680-1684, doi: 10.1038/nm.2555 (2011).
32. Verhoeven, B. A. et al. Athero-express: differential atherosclerotic plaque expression of mRNA and protein in relation to cardiovascular events and patient characteristics. Rationale and design. European journal of epidemiology 19, 1127-1133 (2004).
33. Lewis, M. J. et al. Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 120, 417-426, doi: 10.1161/circulationaha.109.868158 (2009).
34. Vinegoni, C. et al. Indocyanine green enables near-infrared fluorescence imaging of lipid-rich, inflamed atherosclerotic plaques. Sci Transl Med 3, 84ra45, doi: 10.1126/scitranslmed.3001577 (2011).